Loss of HLA class I expression in prostate cancer: Implications for immunotherapy

This publication has 18 references indexed in Scilit:

• A new look for the 1990s
  Nature, 1994
• Interleukin‐2 transfected prostate cancer cells generate a local antitumor effect in vivo
  The Prostate, 1994
• Changes in prostate cancer incidence and treatment in USA
  The Lancet, 1994
• Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
  The Journal of Experimental Medicine, 1994
• Natural history of HLA expression during tumour development
  Immunology Today, 1993
• Identification of human cancers deficient in antigen processing.
  The Journal of Experimental Medicine, 1993
• NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONE
  The Lancet, 1988
• Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancer
  International Journal of Cancer, 1986
• THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANS
  Transplantation, 1984
• Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells
  Nature, 1983